Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$38.13 - $76.93 $165,255 - $333,414
4,334 New
4,334 $205,000
Q1 2022

May 16, 2022

SELL
$56.06 - $74.11 $152,707 - $201,875
-2,724 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$60.19 - $97.37 $163,957 - $265,235
2,724 New
2,724 $204,000
Q4 2019

Feb 14, 2020

SELL
$57.95 - $66.61 $141,745 - $162,928
-2,446 Closed
0 $0
Q3 2019

Nov 08, 2019

BUY
$60.08 - $88.17 $111,268 - $163,290
1,852 Added 311.78%
2,446 $147,000
Q2 2019

Aug 12, 2019

SELL
$81.3 - $97.35 $237,477 - $284,359
-2,921 Reduced 83.1%
594 $50,000
Q1 2019

Apr 29, 2019

BUY
$69.08 - $105.66 $242,816 - $371,394
3,515 New
3,515 $336,000

Others Institutions Holding ENTA

About ENANTA PHARMACEUTICALS INC


  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $103M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track Quantamental Technologies LLC Portfolio

Follow Quantamental Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantamental Technologies LLC with notifications on news.